First AD

Second AD

Around the Practice

Previously recorded peer-to-peer panel discussions featuring authoritative insights, opinions, and perspectives on case presentations and audience engagement on important issues facing today's cancer care professionals.

Lymphoma

Recent Advances in CAR T-Cell Therapy in Lymphoma: Insights from Experts at The John Theurer Cancer Center

 is a virtual event featuring multidisciplinary experts in oncology discussing the latest developments in cancer care as they review patient cases. Every ATP event is unique, and we strive to deliver best-in-class awareness, so the oncology community can learn on-demand.

Key opinion leaders describe when to refer a patient with lymphoma and at what point treatments should be switched, and the evolution of T-cell engaging therapies.

Selecting and Sequencing Therapies to Improve Outcomes in Patients With Lymphoma

Clinical Trial and Real-World Evidence Around CAR T-cell Therapy in LBCL

Selecting the Appropriate Patients and Monitoring Responses to CAR T-Cell Therapy in LBCL

CAR-T therapy in Second-Line Setting in LBCL

Managing Toxicities Associated with CAR-T Therapy in LBCL

Brexucabtagene Autoleucel in Mantle Cell Lymphoma

CAR-T Therapies in the Follicular Lymphoma Treatment Landscape

Role of CAR-T Therapies in Acute Lymphoblastic Lymphoma

Recent Updates on CAR-T Therapies in Chronic Lymphocytic Leukemia

Next Generation of CAR-T Therapies in Lymphoma

Future Perspectives on CAR-T Therapies in Lymphoma